Back
Apple Vs. Akero Therapeutics Industry Stock Comparison
Buy
59
AAPL
Apple
Last Price:
$232.76
Seasonality Move:
9.53%
Buy
69
AKRO
Akero Therapeutics
Last Price:
$49.93
Seasonality Move:
-13.61%
Buy
69
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy, Sell or Hold?
-
The current Akero Therapeutics [AKRO] share price is $49.95. The Score for AKRO is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
-
AKRO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
AAPL Stock Price Chart
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $49.95The current trend is moderately bullish and AKRO is experiencing slight selling pressure.
AAPL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.31 | Sell |
Relative Strength Index (14 RSI): | 48.2 | Sell |
Chaikin Money Flow: | 13815162 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (226.54 - 238.98) | Sell |
Bollinger Bands (100): | (224.88 - 243.84) | Sell |
AKRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 6.76 | Buy |
Relative Strength Index (14 RSI): | 64.15 | Buy |
Chaikin Money Flow: | -84584 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (24.24 - 53.26) | Buy |
Bollinger Bands (100): | (23.77 - 40.49) | Buy |
AAPL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 231.3 | Buy |
20-day SMA: | 230.89 | Buy |
50-day SMA: | 240.28 | Sell |
200-day SMA: | 221.91 | Buy |
8-day EMA: | 231.18 | Buy |
20-day EMA: | 233.02 | Sell |
50-day EMA: | 235.41 | Sell |
200-day EMA: | 222.39 | Buy |
AKRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 54.02 | Sell |
20-day SMA: | 42.05 | Buy |
50-day SMA: | 34.2 | Buy |
200-day SMA: | 27.85 | Buy |
8-day EMA: | 51.73 | Sell |
20-day EMA: | 45.31 | Buy |
50-day EMA: | 37.61 | Buy |
200-day EMA: | 30.47 | Buy |
Apple Earnings Growth & AAPL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.29 per share, a decrease next quarter of $0.75 per share, an increase this year of $0.65 per share, and an increase next year of $0.90 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.89 per share, and a decrease next year of $0.10 per share.
Apple Technical Analysis
Jan 29 | Jan 30 | Jan 31 | Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 7 | Feb 10 | Feb 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | Feb | |||||||||
29 | 30 | 31 | 03 | 04 | 05 | 06 | 07 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Akero Therapeutics Technical Analysis
Jan 29 | Jan 30 | Jan 31 | Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 7 | Feb 10 | Feb 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | Feb | |||||||||
29 | 30 | 31 | 03 | 04 | 05 | 06 | 07 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |